Gene: TMEM250
Official Full Name: transmembrane protein 250provided by HGNC
Gene Summary: Predicted to enable GTPase activity and molecular adaptor activity. Involved in positive regulation of cell population proliferation and positive regulation of viral process. Located in cytoplasm and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03272 | TMEM250 Knockout cell line (HeLa) | Human | TMEM250 | 1:3~1:6 | Negative | Online Inquiry |
KO03273 | TMEM250 Knockout cell line (HCT 116) | Human | TMEM250 | 1:2~1:4 | Negative | Online Inquiry |
KO03274 | TMEM250 Knockout cell line (HEK293) | Human | TMEM250 | 1:3~1:6 | Negative | Online Inquiry |
KO03275 | TMEM250 Knockout cell line (A549) | Human | TMEM250 | 1:3~1:4 | Negative | Online Inquiry |
TMEM250 Gene Knockout Cell Lines are specifically engineered cellular models that have undergone targeted gene disruption of the TMEM250 gene, which is implicated in various cellular processes and diseases. These knockout cell lines serve as invaluable tools for researchers aiming to dissect the biological functions of TMEM250, enabling the exploration of its role in cellular signaling, proliferation, and differentiation pathways.
The key mechanism by which TMEM250 Gene Knockout Cell Lines operate is the complete inactivation of the TMEM250 gene via CRISPR/Cas9 technology or similar genome-editing strategies. By creating a null mutation, users can investigate the downstream effects on cellular homeostasis and pathology, providing insights into mechanisms underlying disease states such as cancer or neurodegenerative disorders. The precision of these knockout models allows for the replication of specific genetic conditions, which is essential for both basic and translational research.
From a scientific standpoint, the applications of TMEM250 Gene Knockout Cell Lines are vast. They can be utilized in drug screening assays, allowing researchers to identify novel therapeutic targets related to TMEM250 expression. In clinical settings, understanding the function of TMEM250 could lead to breakthroughs in diagnostic and prognostic assessments, providing a pathway to personalized medicine strategies.
Compared to alternative models, such as RNA interference or transient expression systems, the TMEM250 Gene Knockout Cell Lines provide a more stable and precise genetic alteration, enabling prolonged studies without the variability associated with less permanent methods. This stability also enhances reproducibility, a critical factor in scientific research.
For researchers and clinicians, the value of TMEM250 Gene Knockout Cell Lines lies in their potential to unlock new scientific understanding and therapeutic options. With the possibility to conduct more reliable and relevant experiments, these models significantly elevate the standard of experimental inquiry.
Our company prides itself on its expertise in developing advanced cellular models tailored for cutting-edge research. By delivering high-quality TMEM250 Gene Knockout Cell Lines, we remain committed to supporting the scientific community in their quest for groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.